Evaluating Diagnostic Strategies Involving Multiple Tests

Published May 17, 2013
Leicester, UK – It is essential that the relationships between diagnostic tests are understood in order to ensure the most effective diagnoses of diseases, as they rarely perform independently. To date, both clinical and economic evaluations of combinations of diagnostic tests have mostly assumed the tests to perform independently of one another. However, doing so will often over-estimate the performance of sequences of diagnostic tests. Researchers from the University of Leicester attempted to show how failure to allow for correlations between test performance may led to erroneous conclusions. By creating a framework for the evaluation of the diagnostic performance of sequences of tests and applying the framework to an economic evaluation of diagnostic strategies for Deep Vein Thrombosis, they determined that allowing for correlations between tests had considerable impact on the evaluation results. Professor Alex Sutton, researcher on the studies says, "As well as presenting a novel method in an under-researched area, this work also has important implications for those designing diagnostic evaluation studies in the future since it highlights the need for studies which evaluate multiple tests." The full studies: “Evaluating the Cost-Effectiveness of Diagnostic Tests in Combination: Is It Important to Allow for Performance Dependency?” and “Meta-Analysis of the Accuracy of Two Diagnostic Tests Used in Combination: Application to the Ddimer Test and the Wells Score for the Diagnosis of Deep Vein Thrombosis” are published in Value in Health.

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

For more information: www.ispor.org

Related Stories

Measuring What Matters: Broadening the Scope of Health Economics Evaluation to Incorporate Well-Being

Jul 9, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health that offer insights into facets of economic evaluation aimed to incorporate well-being into decision making.

Confronting the Backlash Against QALYs: Key Insights From Leading Health Economists

Jun 18, 2024

ISPOR announced the publication of a collection of papers that examine the long-standing debate surrounding the use of quality-adjusted life years (QALYs) and alternative measures in healthcare decision making.

ISPOR Good Practices Report Offers Guidance for Using Real-World Data From EHRs in Health Technology Assessments

Jun 17, 2024

ISPOR announced the publication of an ISPOR Good Practices Report that proposes a framework for assessing the suitability of electronic health records data for use in health technology assessments. The report, “Assessing Real-World Data from Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force” was published in the June 2024 issue of Value in Health.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×